PALB2 and neoplasm: The most promising candidate genes were POLE, ERCC6, RAD54L, and PALB2. The POLE variant (c.1847G > A; p.Arg616His) identified in LLS20 was outside the exonuclease domain, and its respective tumor was not hypermutated and did not present any mutational signatures previously associated with POLE variants.